Speaker: Stew Yang
Learning objectives:
- Review the evolving landscape of predictive biomarkers in NSCLC, including updates from recent approvals
- Discuss the unique benefits and challenges of using immunohistochemistry for comprehensive predictive biomarker testing
- Learn how to interpret and troubleshoot high-yield, clinical-grade markers for FDA-approved therapies and investigational treatments.